Background: Biomarkers play an important role in the diagnosis of early-stage Alzheimer disease (AD), with the hippocampal emerging as the most reliable indicator of AD pathology. Elucidation of the patient's left and right hippocampal volumes warrants further consideration. Therefore, caution should be exercised regarding the constraints inherent in the measurement method. This meta-analysis aimed to determine the left and right hippocampal volume changes and the volume measurement method.
Methods: The PubMed, Web of Science, and Scopus databases were searched and published until September 2023. A total of 29 studies were included in this meta-analysis.
Results: The meta-analysis results indicate a significant reduction in total hippocampal volume in AD patients. The results for the hippocampal volume on the left and right sides of 3 classes, such as AD, mild cognitive impairment (MCI), and normal control (NC), showed a greater reduction on the left side. The results showed in AD: 95% confidence interval (CI) = -142 to 1.61, P = .04, I2 = 44%; MCI: 95% CI= -186 to -72, P = <.00001, I2 = 0%, and NC: 95% CI = -141 to 14, P = .11, I2 = 80%, respectively, with random effect. The left hippocampal in AD is smaller, while the right hippocampal is larger. The AD class significantly reduced hippocampal volume on both the left and right sides.
Conclusion: Notably, automatic segmentation methods impact hippocampal volume measurements, with results potentially relying heavily on their correlation with the manual labeling process.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MD.0000000000041662 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hippocampal volume asymmetry in Alzheimer disease: A systematic review and meta-analysis.
Medicine (Baltimore)
March 2025
Rehabilitation Engineering Lab, Department of Health and Kinesiology, University of Illinois at Urbana-Champaign, Urbana, IL.
Background: Biomarkers play an important role in the diagnosis of early-stage Alzheimer disease (AD), with the hippocampal emerging as the most reliable indicator of AD pathology. Elucidation of the patient's left and right hippocampal volumes warrants further consideration. Therefore, caution should be exercised regarding the constraints inherent in the measurement method.
View Article and Find Full Text PDFcultured calculus bovis alleviates cerebral ischemia-reperfusion injury in rats through regulating microglial polarization and inhibiting NLRP3.
Zhejiang Da Xue Xue Bao Yi Xue Ban
March 2025
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Objectives: To investigate the effect of cultured calculus bovis (ICCB) on cerebral ischemia/reperfusion injury (CIRI) and its mechanism.
Methods: The CIRI animal model and cell model were induced by middle cerebral artery occlusion (MCAO) in Sprague Dawley rats and oxygen glucose deprivation/reperfusion (OGD/R) in BV2 cells, respectively. The CIRI of rat model was evaluated using modified neurological severity score (mNSS), brain water content, and cerebral infarction volume after 1.
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.
Nat Med
March 2025
Longeveron, Miami, FL, USA.
Alzheimer's disease (AD) is characterized by progressive cognitive decline, severe brain atrophy and neuroinflammation. We conducted a randomized, double-blind, placebo-controlled, parallel-group phase 2a clinical trial that tested the safety and efficacy of laromestrocel, a bone-marrow-derived, allogeneic mesenchymal stem-cell therapy, in slowing AD clinical progression, atrophy and neuroinflammation. Participants across ten centers in the United States were randomly assigned 1:1:1:1 to four infusion groups: group 1 (placebo; four monthly infusions, n = 12); group 2 (25 million cells, one infusion followed by three monthly infusions of placebo, n = 13); group 3 (25 million cells; four monthly doses, n = 13); and group 4 (100 million cells; four monthly doses, n = 11).
View Article and Find Full Text PDFCorrelating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer's disease and related neurodegenerative pathologies using 7T postmortem MRI.
J Neuropathol Exp Neurol
March 2025
Department of Pathology, University of Pittsburgh, Pittsburgh, PA, United States.
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC), is common in elderly brains and often seen in conjunction with Alzheimer's disease neuropathologic change (ADNC). LATE-NC typically begins in the amygdala and spreads to the hippocampus and neocortex. Whether it contributes to hippocampal and amygdala atrophy in Down syndrome (DS) remains unexplored.
View Article and Find Full Text PDFAcupuncture alleviates neuro-inflammatory injury in rats with cognitive impairment induced by Parkinson's disease based on cGAS-STING signaling pathway.
Zhen Ci Yan Jiu
February 2025
Department of Encephalopathy.
Objectives: To observe the effect of acupuncture on neuro-inflammation in rats with cognitive impairment induced by Parkinson's disease (PD) based on the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway.
Methods: SD rats were randomly grouped into sham operation, model, acupuncture, acupuncture+empty and acupuncture+cGAS over-expression groups, with 12 rats in each group. The PD model was established by injecting 6-hydroxydopamine (6-OHDA, 8 μg/rat) into the substantia nigra pars compacta of the left midbrain (AP:-5.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!